Literature DB >> 6196297

Characterization of monoclonal antibodies that react with unique and cross-reacting determinants of cholera enterotoxin and its subunits.

R K Holmes, E M Twiddy.   

Abstract

Seventeen selected hybridoma cell lines that produced monoclonal antibodies against cholera enterotoxin (CT) were isolated and characterized. All of the monoclonal antibodies contained the kappa light chain; 14 were of the immunoglobulin G1 (IgG1) isotype and 3 were IgG2a. The 17 monoclonal antibodies were divided into a minimum of seven different specificity groups based on their abilities to bind to the following purified test antigens in solid-phase radioimmunoassays: CT, the A and B polypeptides of CT (CT-A and CT-B, respectively), and the heat-labile enterotoxins designated LTh and LTp from Escherichia coli. The binding of these antibodies to the following subunits and fragments of CT was also determined in Western blots: pentameric CT-B, monomeric CT-B, intact CT-A, and the A1 fragment of CT-A. Each of the monoclonal antibodies was tested for neutralization of CT and for precipitation with CT in immunodiffusion tests. Antigenic determinants were identified on CT that were not present either on CT-A or CT-B. One class was unique for CT and another was shared with LTh and LTp. Antibodies directed against these holotoxin-specific determinants had no neutralizing activity. Most of the monoclonal antibodies that reacted strongly with CT-A or CT-B also reacted strongly with CT holotoxin; however, one class of antibody reacted strongly with CT-A but weakly with CT. Among the monoclonal antibodies against CT-A or CT-B, some were specific for CT and others cross-reacted with LTh and LTp or with LTh only. The most potent neutralizing antibodies were against CT-B, and all of our monoclonal antibodies against CT-B had some neutralizing activity. In contrast, only some of the monoclonal antibodies against CT-A had neutralizing activity, and their specific activities were low. We found no direct correlation between the ability of monoclonal antibodies to neutralize CT and to cross-react with LTh or LTp. None of the epitopes recognized by our monoclonal anti-CT antibodies was present on CT-A and CT-B.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196297      PMCID: PMC264386          DOI: 10.1128/iai.42.3.914-923.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  The arrangement of subunits in cholera toxin.

Authors:  D M Gill
Journal:  Biochemistry       Date:  1976-03-23       Impact factor: 3.162

2.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

3.  The relationship between two apparently different enterotoxins produced by enteropathogenic strains of Escherichia coli of porcine origin.

Authors:  H W Smith; C L Gyles
Journal:  J Med Microbiol       Date:  1970-08       Impact factor: 2.472

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

6.  A fixation method for improved antibody penetration in electron microscopical immunoperoxidase studies.

Authors:  W Bohn
Journal:  J Histochem Cytochem       Date:  1978-04       Impact factor: 2.479

7.  Dissociation and recombination of the subunits of the cholera enterotoxin (choleragen).

Authors:  R A Finkelstein; M Boesman; S H Neoh; M K LaRue; R Delaney
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

Review 8.  Mechanisms of disease and immunity in cholera: a review.

Authors:  J Holmgren; A M Svennerholm
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

9.  Radioimmunoassay for the antigenic determinants of cholera toxin and its components.

Authors:  K E Hejtmancik; J W Peterson; D E Markel; A Kurosky
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

10.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

View more
  45 in total

1.  Transfer of the cholera toxin A1 polypeptide from the endoplasmic reticulum to the cytosol is a rapid process facilitated by the endoplasmic reticulum-associated degradation pathway.

Authors:  Ken Teter; Rebecca L Allyn; Michael G Jobling; Randall K Holmes
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Cholera holotoxin assembly requires a hydrophobic domain at the A-B5 interface: mutational analysis and development of an in vitro assembly system.

Authors:  Juliette K Tinker; Jarrod L Erbe; Wim G J Hol; Randall K Holmes
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

3.  Identification of motifs in cholera toxin A1 polypeptide that are required for its interaction with human ADP-ribosylation factor 6 in a bacterial two-hybrid system.

Authors:  M G Jobling; R K Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

4.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.

Authors:  N A Strockbine; L R Marques; J W Newland; H W Smith; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

5.  Transcription of cholera toxin operon in wild-type and mutant strains of Vibrio cholerae.

Authors:  L Mishra; R K Holmes
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

6.  cAMP-Independent Activation of the Unfolded Protein Response by Cholera Toxin.

Authors:  Tuhina Banerjee; Aby Grabon; Michael Taylor; Ken Teter
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

7.  Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin.

Authors:  A P Wnek; R J Strouse; B A McClane
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

8.  Characterization of an iron-dependent regulatory protein (IdeR) of Mycobacterium tuberculosis as a functional homolog of the diphtheria toxin repressor (DtxR) from Corynebacterium diphtheriae.

Authors:  M P Schmitt; M Predich; L Doukhan; I Smith; R K Holmes
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Characterization of mutations that inactivate the diphtheria toxin repressor gene (dtxR).

Authors:  Z Wang; M P Schmitt; R K Holmes
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice.

Authors:  V L Tesh; J A Burris; J W Owens; V M Gordon; E A Wadolkowski; A D O'Brien; J E Samuel
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.